|
KMID : 0895820160260010013
|
|
Journal of Oriental Rehabilitation Medicine
2016 Volume.26 No. 1 p.13 ~ p.31
|
|
|
Effects of Gami-Handayeolso-Tang on Body Fat Reduction in High Fat Diet-Fed Obese Mice
|
|
Lee Ha-Il
Lee Jong-Ha
Kwon Young-Mi
Song Yung-Sun
|
|
|
Abstract
|
|
|
Objectives: In this study, it was investigated whether Gami-Handayeolso-Tang (HDYST) medication has anti-obesity effects in high fat diet (HFD)-fed obese mice.
Methods : The experimental animals were divided into five groups-normal diet-fed (ND), high fat diet-fed control (HFD), HFD＋HDYST 150, HFD＋HDYST 300, and HFD＋orlistat as a positive drug. The obese markers such as body weight, diet efficiency ratio, serum levels of total cholesterol, triglyceride, lipid contents, leptin, adiponectin, and GOT/GPT were measured. Also, white adipose tissue, liver weight, abdominal fat mass, hepatic lipid contents, and mRNA expression of obese-associating genes were examined in obese mice.
Results : In high fat diet-fed mice, HDYST administration significantly decreased body weight, diet efficiency ratio, serum levels of total cholesterol, triglyceride, LDL-cholesterol, as well as leptin and GOT/GPT, compared to the HFD group in a dose-dependent manner. HDYST increased significantly the serum levels of HDL-cholesterol and adiponectin. It also reduced the accumulation of lipids, such as total lipid and triglycerides, in organs such as liver and abdominal adipose tissue. Moreover, HDYST administration significantly decreased the expression levels of fatty acid synthetic genes, such as sterol regulatory element- binding protein-1c (SREBP-1c), FAS and Stearoyl-Coenzyme A desaturase 1 (SCD-1), in the liver tissues, while it increased the messenger RAN (mRNA) levels of fatty acid catalytic genes, such as Peroxisome proliferator activated receptor alpha (PPAR-α), acyl-COA oxidase (ACO), and Carnitine palmitoyltransferase-1a (CPT-1a).
Conclusions : Based on the results above, HDYST reveals anti-obesity effects declining body fat accumulation through the regulation of fatty acid metabolism and leptin/ adiponectin serum levels. It therefore suggests that HDYST can be clinically useful for the treatment of obesity.
|
|
|
KEYWORD
|
|
|
Gami-Handayeolso-Tang, HDYST, Obesity, High fat diet, Lipid accumulation
|
|
|
FullTexts / Linksout information
|
|
|
|
|
|
Listed journal information
|
|
|
|